U.S. COPD Market - Therapeutic Overview and Patient Outlook


USD 4,950.00

* Required Fields

USD 4,950.00


Be the first to review this product

This research service covers the U.S. COPD market from 2003-2013. Included are patient forecasts and a therapeutic overview. The market is segmented by product class: bronchodilators, anti-inflammatories, combination therapies, and novel therapeutic approaches. The novel therapeutic approaches segment covers selected products in the pipeline that are outside current marketed segments. Major market challenges, drivers, restraints, and strategic recommendations to overcome market challenges are also discussed.

Table of Contents

U.S. COPD Market - Therapeutic Overview and Patient Outlook, Executive SummaryExecutive SummaryIntroductionU.S. COPD Market - Therapeutic Overview and Patient Outlook, Total MarketResearch Scope and MethodologyScope and SegmentationResearch MethodologyDisease OverviewIntroductionDisease DefinitionSymptomsRisk FactorsDiagnosisTreatmentsDrug Delivery MethodsDisease StatisticsCompetitive StructurePatient OutlookPatient ForecastsGeneral Market TrendsChallengesStrategic Recommendations for ChallengesMarket DriversMarket RestraintsU.S. COPD Market - Therapeutic Overview and Patient Outlook, Marketed Therapies OverviewOverviewBronchodilatorsAnti-inflammatoriesCombination TherapiesNovel Therapeutic ApproachesU.S. COPD Market - Therapeutic Overview and Patient Outlook, AppendixDecision Support DatabasesChronic Obstructive Pulmonary Disease PopulationPrevalence of Male SmokersPrevalence of Female SmokersPopulation 65 and OverPrevalence of Asthma

Why Frost & Sullivan

Working with the CEO’s growth team to create a vision based on a transformation growth strategy

Creating content-based digital marketing strategies that leverage our research perspective to differentiate and “tell your story”

Tracking over 1000 emerging technologies and analyzing the impact by industry and application to reveal the companies to watch in each sector

The Frost & Sullivan team is based in our 45 global offices and have developed a powerful global understandings of how industries operate on a global level.